Biodextris

News & Events

December 17, 2024
Learn about the strategic partnership between Aramis Biotechnologies and Biodextris to advance vaccine and biologics development.
Biodextris Inc. inaugurates its new facilities in the heart of Laval's Biotech City
By Philippe Beland October 9, 2024
Biodextris inaugurates its new Laval facility in Biotech City, expanding its capabilities in biologics development and manufacturing.
cGMP biomanufacturing facility Laval
June 5, 2024
Discover Biodextris' new cGMP biomanufacturing and analytical facility. Check out our state-of-the-art capabilities.
February 16, 2024
Discover how Quality by Design (QbD) helps streamline biologics development, reduce costs, and improve product outcomes in complex CDMO environments.
October 24, 2023
Explore how a project-based CDMO collaboration model ensures better flexibility, transparency, and outcomes in biologics development.
By Cedric Heroux June 6, 2023
Biodextris and Calder Biosciences partner for a Phase 1 RSV vaccine trial. Read how this collaboration accelerates vaccine innovation.
Biodextris commissions a custom-designed cGMP biomanufacturing and analytical facility
By The Website Store September 14, 2022
Biodextris launches a new cGMP facility designed for advanced biomanufacturing and analytical services. See what this means for your next project.
Is cell culture to replace microbial fermentation?
By The Website Store May 13, 2022
Explore whether cell culture is replacing microbial fermentation in biologics manufacturing—and what this shift means for CDMO strategy and innovation.
Why is process development such a lengthy activity?
By The Website Store March 18, 2022
Why is process development so complex and time-consuming in biologics? Get insights into key challenges and solutions for accelerating timelines.
More Posts